Join
Live feed
·
INSIDERFilingvia Quantisnow
Revance Therapeutics Inc. logo

SEC Form 4: Foley Mark J was granted 122,143 shares and covered exercise/tax liability with 48,064 shares, increasing direct ownership by 9% to 914,454 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVNC (Revance Therapeutics Inc.) and more on Quantisnow.